FULCRUM THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
FULCRUM THERAPEUTICS, INC. (FULC) reported Increase (Decrease) in Accounts Payable of $1.83 million for the 6-month period ending 2026-06-30, per its S-4 filed 2026-09-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-09-02
- FULCRUM THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $975.00K, a 299.59% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $858.00K, a 150.15% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.10M.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $946.00K, a 218.52% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2023 was -$853.00K.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2022 was -$1.18M, a 220.86% decline from fiscal 2021.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2021 was $973.00K, a 45.12% decline from fiscal 2020.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2020 was $1.77M, a 120.80% increase from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $975.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-09-02 | $1.83M S-4 · filed 2026-09-02 | $728.00K derived: sum of 3 quarters · filed 2026-09-02 | $1.67M derived: sum of 4 quarters · filed 2026-09-02 |
| 2026-03-31 | $858.00K 10-Q · filed 2026-04-27 | -$247.00K derived: sum of 2 quarters · filed 2026-09-02 | $699.00K derived: sum of 3 quarters · filed 2026-09-02 | $943.00K derived: sum of 4 quarters · filed 2026-09-02 |
| 2025-12-31 | -$1.10M derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | -$159.00K derived: sum of 2 quarters · filed 2026-09-02 | $85.00K derived: sum of 3 quarters · filed 2026-09-02 | $428.00K S-4 · filed 2026-09-02 |
| 2025-09-30 | $946.00K derived: 10-Q 9 month − S-4 6 month · filed 2025-10-29 | $1.19M derived: sum of 2 quarters · filed 2026-09-02 | $1.53M 10-Q · filed 2025-10-29 | -$1.16M derived: sum of 4 quarters · filed 2026-09-02 |
| 2025-06-30 | $244.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-09-02 | $587.00K S-4 · filed 2026-09-02 | -$2.11M derived: sum of 3 quarters · filed 2026-09-02 | -$1.81M derived: sum of 4 quarters · filed 2026-09-02 |
| 2025-03-31 | $343.00K 10-Q · filed 2026-04-27 | -$2.35M derived: sum of 2 quarters · filed 2026-09-02 | -$2.06M derived: sum of 3 quarters · filed 2026-09-02 | -$2.35M derived: sum of 4 quarters · filed 2026-09-02 |
| 2024-12-31 | -$2.70M derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | -$2.40M derived: sum of 2 quarters · filed 2026-09-02 | -$2.69M derived: sum of 3 quarters · filed 2026-09-02 | -$1.59M S-4 · filed 2026-09-02 |
| 2024-09-30 | $297.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $4.00K derived: sum of 2 quarters · filed 2025-10-29 | $1.10M 10-Q · filed 2025-10-29 | $287.00K derived: sum of 4 quarters · filed 2025-10-29 |
| 2024-06-30 | -$293.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $807.00K 10-Q · filed 2025-07-29 | -$10.00K derived: sum of 3 quarters · filed 2025-07-29 | -$297.00K derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-01 | $283.00K derived: sum of 2 quarters · filed 2025-05-01 | -$4.00K derived: sum of 3 quarters · filed 2025-05-01 | $159.00K derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | -$817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$1.10M derived: sum of 2 quarters · filed 2025-02-25 | -$941.00K derived: sum of 3 quarters · filed 2025-02-25 | -$853.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | -$287.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$124.00K derived: sum of 2 quarters · filed 2024-11-13 | -$36.00K 10-Q · filed 2024-11-13 | $867.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $251.00K 10-Q · filed 2024-07-31 | $1.15M derived: sum of 3 quarters · filed 2024-07-31 | -$1.40M derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | $88.00K 10-Q · filed 2024-05-13 | $991.00K derived: sum of 2 quarters · filed 2024-05-13 | -$1.56M derived: sum of 3 quarters · filed 2024-05-13 | -$1.60M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$1.65M derived: sum of 2 quarters · filed 2024-02-27 | -$1.69M derived: sum of 3 quarters · filed 2024-02-27 | -$1.18M 10-K · filed 2024-02-27 |
| 2022-09-30 | -$2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$2.59M derived: sum of 2 quarters · filed 2023-11-07 | -$2.08M 10-Q · filed 2023-11-07 | -$903.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $471.00K 10-Q · filed 2023-08-03 | $1.65M derived: sum of 3 quarters · filed 2023-08-03 | $822.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $509.00K 10-Q · filed 2023-05-15 | $1.69M derived: sum of 2 quarters · filed 2023-06-26 | $860.00K derived: sum of 3 quarters · filed 2023-06-26 | $562.00K derived: sum of 4 quarters · filed 2023-06-26 |
| 2021-12-31 | $1.18M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | $351.00K derived: sum of 2 quarters · filed 2023-06-26 | $53.00K derived: sum of 3 quarters · filed 2023-06-26 | $973.00K 10-K/A · filed 2023-06-26 |
| 2021-09-30 | -$825.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.12M derived: sum of 2 quarters · filed 2022-11-08 | -$203.00K 10-Q · filed 2022-11-08 | -$20.00K derived: sum of 4 quarters · filed 2023-06-26 |
| 2021-06-30 | -$298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $622.00K 10-Q · filed 2022-08-11 | $805.00K derived: sum of 3 quarters · filed 2023-06-26 | $959.00K derived: sum of 4 quarters · filed 2023-06-26 |
| 2021-03-31 | $920.00K 10-Q · filed 2022-05-09 | $1.10M derived: sum of 2 quarters · filed 2023-06-26 | $1.26M derived: sum of 3 quarters · filed 2023-06-26 | $1.26M derived: sum of 4 quarters · filed 2023-06-26 |
| 2020-12-31 | $183.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | $337.00K derived: sum of 2 quarters · filed 2023-06-26 | $344.00K derived: sum of 3 quarters · filed 2023-06-26 | $1.77M 10-K/A · filed 2023-06-26 |
| 2020-09-30 | $154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $161.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.59M 10-Q · filed 2021-11-04 | -$456.00K derived: sum of 4 quarters · filed 2023-06-23 |
| 2020-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $1.44M 10-Q · filed 2021-08-10 | -$610.00K derived: sum of 3 quarters · filed 2023-06-23 | $1.79M derived: sum of 4 quarters · filed 2023-06-23 |
| 2020-03-31 | $1.43M 10-Q · filed 2021-05-06 | -$617.00K derived: sum of 2 quarters · filed 2023-06-23 | $1.78M derived: sum of 3 quarters · filed 2023-06-23 | $999.00K derived: sum of 4 quarters · filed 2023-06-23 |
| 2019-12-31 | -$2.05M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-23 | $352.00K derived: sum of 2 quarters · filed 2023-06-23 | -$430.00K derived: sum of 3 quarters · filed 2023-06-23 | $803.00K 10-K/A · filed 2023-06-23 |
| 2019-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $1.62M derived: sum of 2 quarters · filed 2020-11-10 | $2.85M 10-Q · filed 2020-11-10 | $2.70M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | -$782.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $451.00K 10-Q · filed 2020-08-11 | $299.00K derived: sum of 3 quarters · filed 2020-08-11 | -$72.00K derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | $1.23M 10-Q · filed 2020-05-13 | $1.08M derived: sum of 2 quarters · filed 2020-05-13 | $710.00K derived: sum of 3 quarters · filed 2020-05-13 | |
| 2018-12-31 | -$152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | -$523.00K derived: sum of 2 quarters · filed 2020-03-05 | -$20.00K 10-K · filed 2020-03-05 | |
| 2018-09-30 | -$371.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $132.00K 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $503.00K 10-Q · filed 2019-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |